The T1D Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent, and ultimately cure T1D.  Launched in December 2016, our aim is to attract and deploy capital to advance promising disease-modifying therapies and provide cures for those living with T1D.  It’s the first scaled, mission-driven venture philanthropy fund focused on equity investments in partnership with additional sources of capital, including venture capital, corporations, and foundations.  By investing in areas strategically aligned with Breakthrough T1D (Formerly JDRF), the leading global T1D research and advocacy organization, we can exclusively focus on supporting innovative approaches and novel mechanisms with curative potential.  We are a mission-driven organization that continues to support companies that play a role in the discovery and therapeutic development of effective solutions to T1D. 

Biotechnology

Health Care

Life Sciences

Therapeutics

Venture Capital

T1D Fund

T1D Fund's headquarters in Boston, United States

Daniel Flicker

Morgan Janes

This department provides expert guidance and support to the organization on various strategic initiatives.

Advisory Services

This department oversees strategic direction and operational management across the organization.

Leadership and Strategy

This department focuses on managing client relationships and ensuring customer satisfaction.

Client Services

This department oversees the strategic direction and operational management of the organization.

T1D Fund

Org chart

Teams

Advisory Services

Leadership and Strategy

Client Services

Executive Leadership

Offices

T1D Fund

Org chart

Teams

Advisory Services

Leadership and Strategy

Client Services

Executive Leadership

Offices

Related companies